On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Avastin for Refractory Glioblastoma and Oxaliplatin for Colon Cancer
June 6th 2008As presented at ASCO, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge for refractory glioblastoma. Also presented at the ASCO meeting, adding oxaliplatin (Eloxatin) to a standard chemotherapy regimen for stage II or III colon cancer may provide a small five-year survival advantage.
Maximizing College Aid (Legally)
May 29th 2008Susie just got her acceptance letter to a big-name university and now you're trying to figure out how to pay for it and whether you could possibly qualify for financial aid. Tip: the key strategies to maximize financial aid eligibility are to reduce assets or income or both.